Hologic, Inc. - Common Stock (NQ:HOLX)

76.01 UNCHANGED

Last Price Updated: 4:00 PM EDT, Apr 6, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Hologic, Inc. - Common Stock

< Previous 1 2

...

12 13 14 15 16 17 18 19 Next >

Amazon, bluebird bio And 3 Stocks To Watch Heading Into Monday ↗

September 26, 2022

With US stock futures trading lower this morning on Friday, some of the stocks that may grab investor focus today are as follows:

Via Benzinga

COVID-19 Complacency Pushes Identification Of New Variants To Back Seat, WHO Warns ↗

September 23, 2022

The World Health Organization (WHO) warned that it struggles to identify and

Via Benzinga

More than 1.5 Billion Women Worldwide Lack Essential Health Screenings

September 21, 2022

From Hologic, Inc.

Via Business Wire

Analyst Ratings for Hologic ↗

July 18, 2022

Within the last quarter, Hologic (NASDAQ:HOLX) has observed the following analyst ratings:

Via Benzinga

Expert Ratings for Hologic ↗

May 17, 2022

Analysts have provided the following ratings for Hologic (NASDAQ:HOLX) within the last quarter:

Via Benzinga

Lower COVID-19 Assay Sales Weighs On Hologic's Q2 Revenue ↗

April 28, 2022

Via Benzinga

Hologic to Webcast Presentations at Upcoming Investor Conferences

August 30, 2022

From Hologic, Inc.

Via Business Wire

No More Free COVID-19 At-Home Tests, Federal Government Says ↗

August 29, 2022

CNBC reported that the federal government is set to suspend its offer of free at-home COVID-19 tests by Friday, September 2, without congressional au

Via Benzinga

Hologic and Mary J. Blige Launch “Good Morning Gorgeous” Sweepstakes as a Wake-up Call to Increase Awareness of the Importance of Preventive Care

August 12, 2022

From Hologic, Inc.

Via Business Wire

Expert Ratings for Hologic ↗

April 25, 2022

Analysts have provided the following ratings for Hologic (NASDAQ:HOLX) within the last quarter:

Via Benzinga

U.S. Court of Appeals for the Federal Circuit Affirms 2018 Ruling Barring Minerva from Challenging Hologic’s Patent Rights

August 11, 2022

From Hologic, Inc.

Via Business Wire

Hologic's Return On Capital Employed Overview ↗

July 28, 2022

Pulled from Benzinga Pro data, Hologic (NASDAQ:HOLX) posted Q3 earnings of $228.40 million, an increase from Q2 of 49.88%. Sales dropped to $1.00 billion, a 30.15% decrease between quarters.

Via Benzinga

Hologic Announces Financial Results for Third Quarter of Fiscal 2022

July 27, 2022

From Hologic, Inc.

Via Business Wire

7 Nasdaq Stocks Trading at a Huge Discount Right Now ↗

July 15, 2022

With the markets performing worse than they have in years, finding Nasdaq stocks trading at a discount is easier than ever.

Via InvestorPlace

Benzinga's Top Ratings Upgrades, Downgrades For July 20, 2022 ↗

July 20, 2022

Upgrades

Via Benzinga

Hologic to Announce Financial Results for the Third Quarter of Fiscal 2022 on Wednesday, July 27, 2022

July 05, 2022

From Hologic, Inc.

Via Business Wire

New Survey Reveals Lack of Knowledge among U.S. Women about Uterine Health, Including Fibroid Symptoms and Treatment Options

July 01, 2022

From Hologic, Inc.

Via Business Wire

Augmented Realty and Virtual Reality in Healthcare Market Size, Share, Trends, Industry Analysis, Growth, Business Plan, Opportunities and Forecast 2022-2028

June 02, 2022

Global Augmented Realty and Virtual Reality in Healthcare Market Dynamics 2022-2028, Regional Analysis, Segmentation, Competitive Landscape, COVID-19 Impact, Recent Developments and SWOT Analysis of...

Via SBWire

Medical Imaging Informatics Market New Innovations Trends, Research, Global Share and Growth Factor

May 17, 2022

Medical Imaging Informatics Market New Innovations Trends, Research, Global Share and Growth Factor According to a new report published by Allied Market Research, titled, The medical imaging...

Via iCrowdNewswire

Hologic Board Member, Sally W. Crawford, Recognized As NACD Directorship 100™ Honoree

May 17, 2022

From Hologic, Inc.

Via Business Wire

Laser Hair Removal Service Market Size, Share, Trends & Analysis by Application, Technology, Key Companies, Opportunities and Forecast 2022–2028

May 16, 2022

Intelligence Market Report Publish New Research Report On-“Laser Hair Removal Service 2022 Market Analysis by Key Players, Applications, Growth Trends, Share & Segment Forecast to 2028”

Via SBWire

CNBC's Final Trades: Charles Schwab And These 3 Medical Stocks ↗

May 12, 2022

On CNBC’s “Halftime Report Final Trades,” Karen Firestone of Aureus Asset Management said Charles Schwab Corporation (NYSE: SCHW) is trading at 14 times next year’s earnings.

Via Benzinga

15 Stocks Moved By Traders on 'Fast Money: Halftime Report' ↗

May 11, 2022

CNBC’s "Fast Money: Halftime Report" delivers market-moving news to investors. The commentary delivered by hosts of the show often moves the stocks mentioned. The...

Via Benzinga

Hologic Announces FDA Approval of Aptima® CMV Quant Assay for Human Cytomegalovirus

May 10, 2022

From Hologic, Inc.

Via Business Wire

Hologic to Webcast Presentation at Upcoming Investor Conference

May 04, 2022

From Hologic, Inc.

Via Business Wire

Hologic's Return On Capital Employed Overview ↗

April 29, 2022

Pulled from Benzinga Pro data, Hologic (NASDAQ:HOLX) posted Q2 earnings of $455.70 million, an increase from Q1 of 8.71%. Sales dropped to $1.44 billion, a 2.38% decrease between quarters.

Via Benzinga

Raymond James Maintains Outperform Rating for Hologic: Here's What You Need To Know ↗

April 28, 2022

Raymond James has decided to maintain its Outperform rating of Hologic (NASDAQ:HOLX) and lower its price target from $84.00 to $83.00. Shares of Hologic are trading down 2.08% over the last 24 hours,...

Via Benzinga

Hologic Announces Financial Results for Second Quarter of Fiscal 2022

April 27, 2022

From Hologic, Inc.

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For April 25, 2022 ↗

April 25, 2022

Via Benzinga

American Society of Clinical Oncology (ASCO) Clinical Practice Guideline Now Includes Breast Cancer Index™ to Guide Decisions about Extended Endocrine Therapy

April 25, 2022

From Hologic, Inc.

Via Business Wire

< Previous 1 2

...

12 13 14 15 16 17 18 19 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.